Mitochondrial Transplantation: State of the Art
80% efficacy in pediatric cardiac patients. Isolation protocols, delivery methods, and what the transcriptomics reveal about why it works.
Mitochondria are 30% of cardiac cell volume. They provide all the energy for the heart to contract. When oxygen delivery stops, the damage is immediate and cascading. The mitochondria swell, their cristae break apart, calcium accumulates inside them, and the surrounding tissue ruptures.
This is ischemia-reperfusion injury. The number one killer in cardiac medicine.
For decades, researchers tried to fix this by going upstream or downstream of the mitochondria. Various agents, various protocols. None of them worked particularly well.
Then in 2007, a team at Boston Children’s Hospital had a different idea: what if you just replace the damaged organelles?
The protocol
Take two small pieces of healthy tissue from the patient. A number six biopsy punch. The same thing a dermatologist uses to check a suspicious mole. From those two pieces, you can isolate roughly 10 x 10^10 viable mitochondria. You only need 10^9. Ten times more than you’d ever use.
The isolation takes minutes, not hours. Earlier methods required two hours of repeated centrifugation and produced messy product. The current protocol uses a series of filters and happens on the bench right beside the patient.
The requirements are strict: mitochondria must be intact, viable, and respiration competent. Dead mitochondria, mitochondrial DNA fragments, and respiration-incompetent mitochondria do nothing. But it doesn’t matter whether they come from fast twitch or slow twitch muscle. It doesn’t matter which organ they’re sourced from. They all work.
Delivery methods
Three routes:
Direct injection. Mitochondria stay fairly localized at the injection site. Simple. Used when the chest is already open.
Catheter delivery. Inject directly into the target organ via catheter. The mitochondria distribute throughout the target tissue.
Aerosol. For the lungs. Everything lights up on imaging. Works just as well as vascular delivery.
Once delivered, the mitochondria are taken up by cells within minutes. At 2.5 minutes (the shortest timepoint they could measure), uptake was already visible. The mechanism is endocytosis, the same billion-year-old process by which the original mitochondrial endosymbiosis occurred.
There is no immune response. No inflammatory response. You can take mitochondria from one person and put them in another.
Clinical results
16 pediatric patients with congenital heart defects. 80% efficacy rate. No safety effects observed.
The transcriptomic data reveals upregulation of anti-apoptosis pathways, muscle development genes, and cardiac development pathways. The transplanted mitochondria aren’t just replacing broken ones. They’re triggering a recovery cascade.
Beyond the heart
The same approach works in kidneys (renal artery delivery), lungs (aerosol or pulmonary artery), skeletal muscle (direct injection), and aged muscle recovery. The organelle doesn’t care which organ it’s in. It cares about being intact and being able to respire.
This is one of those findings that makes you rethink the unit of intervention. We’ve been targeting molecules, genes, pathways. What if the right unit is the organelle itself?
Based on the keynote presentation from Northwell Health, December 2025. Source